Genome Editing/Genome Engineering Market Report 2026

Genome Editing/Genome Engineering Market Overview

• Genome Editing/Genome Engineering market size has reached to $10.17 billion in 2025 • Expected to grow to $24.53 billion in 2030 at a compound annual growth rate (CAGR) of 19.2% • Growth Driver: The Surge In Research Activities Are Fueling Market Growth • Market Trend: Strategic Partnership To Strengthen Position • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genome Editing/Genome Engineering Market?

Genome editing is a technique that enables scientists to alter the DNA of numerous organisms, including plants, bacteria, and animals. With the help of genome editing technologies, researchers would alter DNA, changing physical characteristics like eye color and the risk of contracting diseases. Genome editing is used in animal models and cells in research labs to understand diseases. The main types of products and services in genome editing and genome engineering are reagents and consumables, software and systems, and services. The reagents and consumables are used at specific locations in the genome of a target organism to cause breaks, repairs, or mismatches involving endogenous mechanisms to cause specific changes in DNA sequence. Consumables are items that can be used up until they run out and then need to be disposed of. A compound or substance that can speed up a reaction is called a reagent. The technology used are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nucleases (ZFN), antisense, and other technologies, which are applied in cell line engineering, genetic engineering, diagnostic applications, drug discovery and development, and other applications, that are used by biotechnology companies, pharmaceutical companies, academic and government research institutes.

What Is The Genome Editing/Genome Engineering Market Growth Forecast?

The genome editing/genome engineering market size is expected to see rapid growth in the next few years. It will grow to $24.53 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to clinical translation of gene editing therapies, expansion of agricultural genomics, improved editing accuracy, ethical framework development, commercialization of genome editing services. Major trends in the forecast period include increasing adoption of crispr-based editing tools, expansion of genome editing in disease research, rising use of cell line engineering applications, growing demand for precision gene modification, increased academic and government research funding.

Global Genome Editing/Genome Engineering Market Segmentation

1) By Product And Service: Reagents And Consumables, Software And Systems, Services 2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies 3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications 4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes Subsegments: 1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents 2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems 3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

What Is The Driver Of The Genome Editing/Genome Engineering Market?

An increase in research activities is expected to drive the growth of the genome editing and genome engineering market going forward. Research activities refer to systematic and organized efforts conducted by individuals, teams, or institutions to gather, analyze, interpret, and generate new knowledge or insights in a particular field of study. Genome editing and genome engineering have become pivotal catalysts in the surging tide of research activities, transforming the landscape of scientific exploration. These revolutionary tools empower researchers to meticulously modify and comprehend the intricate genetic fabric of organisms, offering unparalleled precision and versatility. For instance, in July 2023, according to National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH awards more than $140 million to help accelerate genome editing approaches from the lab to the clinic. Therefore, an increase in research activities is driving the genome editing and genome engineering market.

Key Players In The Global Genome Editing/Genome Engineering Market

Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Global Genome Editing/Genome Engineering Market Trends and Insights

Major companies collaborate and get into partnerships to strengthen their position in the genome editing and genome engineering market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, In April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company with a focus on developing medicines in immunology, oncology, and genetic diseases, entered into a collaboration with Mammoth Biosciences, a US-based biotech firm founded by Jennifer Doudna that specializes in CRISPR-based gene editing. With this partnership, Regeneron aims to leverage Mammoth’s ultra-small CRISPR platforms together with Regeneron’s delivery technologies to accelerate the development of in vivo gene editing therapies for tissues beyond the liver, thereby expanding Regeneron’s therapeutic pipeline and technological reach. Mammoth Biosciences is a U.S.-based company providing CRISPR-based genome editing systems (including its proprietary small Cas enzymes) for therapeutic and diagnostic applications.

What Are Latest Mergers And Acquisitions In The Genome Editing/Genome Engineering Market?

In February 2023, Ensoma, a US-based genomic medicines company developing in vivo cell therapies, acquired Twelve Bio for an undisclosed amount. With this acquisition, Ensoma aims to integrate Twelve Bio’s next-generation CRISPR-Cas12a technology into its Engenious platform to enhance genome-engineering capabilities and accelerate the development of in vivo genomic therapies, thereby strengthening its technological position in the genome editing market. Twelve Bio is a Denmark-based provider of advanced CRISPR-Cas gene editing tools, specializing in Cas12a engineering for therapeutic applications.

Regional Outlook

North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genome Editing/Genome Engineering Market?

The genome editing/genome engineering market includes revenues earned by entities through cell line engineering, animal genetic engineering, and plant genetic engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genome Editing/Genome Engineering Market Report 2026?

The genome editing/genome engineering market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genome editing/genome engineering industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.